- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07284355
Barriers of General Practitioner Regarding Helicobacter Pylori.
Knowledge, Attitude, Practices and Barriersof General Practitioner RegardingHelicobacter Pylori Diagnosis andTreatment
Study Overview
Status
Conditions
Detailed Description
This study explores the knowledge, attitudes, and practices of general practitioners regarding the diagnosis and treatment of Helicobacter pylori infection. It also examines the barriers that may affect appropriate clinical decision-making in managing this common gastrointestinal condition. By assessing physicians' understanding of recommended diagnostic techniques, treatment regimens, and follow-up strategies, the study aims to identify areas where education or system-level improvements may be needed.
The study hypothesizes that insufficient knowledge of current guidelines, limited access to diagnostic tests, and patient-related or system-related barriers contribute to inconsistent management of H. pylori infection among general practitioners. The findings may help inform future training programs and improve patient care outcomes.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Mohanad Abd_Elaleem Sayed
- Phone Number: 01122085058
- Email: Mohanadabdelalim@gmail.com
Study Contact Backup
- Name: Mohamed Abdel-Sabour Mohamed Mekky Abdel-Sabour Mohamed Mekky
- Phone Number: +20 10 12569456
- Email: m.mekky@aun.edu.eg
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
cross-sectional, observational study.
Conducted in primary health care centers,
outpatient clinics, and general hospitals in Up
Egypt (e.g., Assiut, Sohag, Qena, Minya, Luxo
Aswan).
Description
Inclusion Criteria:
- Licensed general practitioners actively working primary health care centers, outpatients clinics and general hospitals in Upper Egypt( Assuit, Minya, Sohag, Qena, luxor and Aswan).
Exclusion Criteria:
- Specialists in gastroenterology.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Demographic , knowledge , Practices , attitude and barriers
Section A: demographic data (age, gender, years of experience, workplace) Section B: knowledge (transmission, symptoms, diagnostic methods,.
treatment guidelines) Section C: attitude (perceived importance, confidence in diagnosis/treatment) Section D: practice (frequency of testing, treatment regimen used).
Section E: barriers (e.g., Lack of resources, guidelines, time constraints, patient adherence)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Knowledge
Time Frame: After history and examination by 1 hour.
|
Level of knowledge about H. pylori infection among General Practitioners" "Measured using a questionnaire of X items (e.g., 15 multiple-choice questions).
The total knowledge score will be calculated as the percentage of correct answers."
|
After history and examination by 1 hour.
|
|
Attitudes
Time Frame: After history and examination by 1 hour.
|
Attitudes of General Practitioners towards diagnosis and treatment of H. pylori infection" "Measured using an X-point Likert scale (e.g., 5-point) on Y items (e.g., 10 statements).
A mean score will be calculated for each participant."
|
After history and examination by 1 hour.
|
|
Practices
Time Frame: After history and examination by 1 hour.
|
Clinical practices of General Practitioners in managing H. pylori infection" "Measured using questions regarding frequency of testing and types of treatment regimens prescribed.
Percentages for each practice will be calculated."
|
After history and examination by 1 hour.
|
|
Perceived Barriers
Time Frame: After history and examination by 1 hour.
|
Barriers reported by General Practitioners in diagnosing and treating H. pylori infection" "Measured using a checklist or Likert scale containing specific barriers (e.g., lack of resources, time constraints, guideline clarity).
Frequencies or scores for each barrier will be calculated."
|
After history and examination by 1 hour.
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- Helicobacter Pylori
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on H.Pylori Infection
-
Soonchunhyang University HospitalCompletedH.Pylori InfectionKorea, Republic of
-
Hamdard UniversityCompleted
-
Soonchunhyang University HospitalRecruiting
-
Soonchunhyang University HospitalCompleted
-
Soonchunhyang University HospitalCompleted
-
Dow University of Health SciencesRecruitingH.Pylori Infection | H.Pylori Eradication Rate | H. Pylori Gastrointestinal DiseasePakistan
-
Chinese University of Hong KongNot yet recruitingH.Pylori Infection
-
Javeriana UniversityUniversidad Nacional de ColombiaCompletedTherapy | H.Pylori Infection | CYP2C19 Polymorphism
-
Helwan UniversityCompleted